knee arthroscopy. Periprosthetic fracture around internal prosthetic right knee joint, subsequent encounter
Conditions
Interventions
Intervention 1: . Intervention group 1: 100 milligeram magnesium sulfate without preservative (magnesium sulfate used will be 10% and manufactured by Pasteur Institute pharmaceutical company, Tehran-I
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 18 to 60 years both sexes ASA class 1 and 2 No history of drug use No history of chronic use of painkillers Lack of sensitivity to the drugs used in this study Absence of liver and kidney failure Absence of underlying disease such as high blood pressure, diabetes, history of infection and malignancy, coagulation diseases Candidate patients for knee arthroscopy Absence of body mass index greater than 30 Absence of cardiovascular problems and arrhythmia Lack of psychological problems Absence of peripheral and central neuropathy Absence of local infection in the spinal area
Exclusion criteria
Exclusion criteria: The patient's lack of consent to continue participating in the study The patient's refusal to perform spinal anesthesia Failure to perform spinal anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Recovery and 1, 6, 24 hours after surgery. Method of measurement: Visual Analogue Scale.;Average analgesic drug consumption. Timepoint: End of study. Method of measurement: Hospital file. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Alireza Sosanabadi
Arak University of Medical Sciences
Outcome results
None listed